shutterstock-140412928edit
Gajus / Shutterstock.com
1 August 2016Big Pharma

Gilead wins second Sovaldi domain dispute

The Alternative Dispute Resolution Forum has ruled in a case between Gilead Sciences and a company called PublicDomainRegistry.com, in another battle centred on Gilead’s hepatitis C drug Sovaldi (sofosbuvir).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
21 July 2016   Gilead Sciences has successfully transferred a domain name that included the term ‘Sovaldi’, one of the drug maker’s products.

More on this story

Americas
21 July 2016   Gilead Sciences has successfully transferred a domain name that included the term ‘Sovaldi’, one of the drug maker’s products.

More on this story

Americas
21 July 2016   Gilead Sciences has successfully transferred a domain name that included the term ‘Sovaldi’, one of the drug maker’s products.